From October 30 to November 1, 2025, the 9th Oriental Congress of Urology and Andrology (OCUA2025) will be held at the Shanghai International Conference Center (No. 2727, Binjiang Avenue, Pudong New District, Shanghai). The event is jointly organized by the Shanghai Medical Association, the Urology Branch of the Shanghai Medical Association, and the Andrology Branch of the Shanghai Medical Association. The conference will focus on "Focusing on Cutting-edge Technologies and Promoting Discipline Development," aiming to build a high-end academic exchange platform for urology and andrology in Asia and promote the deep integration of clinical practice and scientific research innovation.

We warmly invite you to visit and guide us at Booth B04

As a leader in the innovation of andrology diagnosis and treatment technologies, WBL Medical Group will showcase several of its core products developed in-house at Booth B04. Key technological achievements to be displayed include:

LIPUS Low-Intensity Pulsed Ultrasound ED Treatment Platform: Based on non-invasive energy focusing technology, this platform improves local blood circulation and tissue repair in patients with erectile dysfunction (ED) by precisely adjusting ultrasound parameters, offering a safe and effective treatment option for clinical practice.

Extracorporeal Pulsed Ultrasound Pelvic Floor Treatment Platform: Targeting chronic pelvic pain syndrome (CPPS) and pelvic floor dysfunction, this platform utilizes customized energy output and an intelligent temperature control system to achieve non-invasive, personalized pelvic floor muscle repair, improving patients' quality of life.

Penile Hardness Measurement Device: Using high-precision sensors and digital analysis technology, this device objectively evaluates penile rigidity, providing quantifiable data for the diagnosis and monitoring of ED, supporting accurate clinical diagnosis and treatment.

All of these devices have undergone strict quality control and multi-center clinical validation, demonstrating WBL's technological accumulation and clinical transformation capabilities in the field of andrology treatment. The group looks forward to in-depth communication with domestic and international experts at this conference, jointly exploring innovative paths for andrology diagnosis and treatment.

WBL LIPUS Technology Principles and Treatment Effects

The core mechanism of WBL LIPUS is the use of low-energy pulsed ultrasound (with an intensity range of 50-350 mW/cm²) to act on the penile cavernous tissue, activating endogenous stem cells, promoting vascular and nerve regeneration, and repairing damaged vascular endothelium and nerve matrices. This improves erectile function at a pathological level. Compared to traditional oral medications (such as PDE5 inhibitors), prosthetic implants, or invasive therapies (such as intracavernosal injection), WBL LIPUS is a safe, non-invasive treatment option that does not produce drug dependency, side effects, or surgical-related complications.

Competitive Advantages of WBL LIPUS

1. Non-Invasiveness and Safety:

No need for drugs or surgery, avoiding liver and kidney burden and infection risks, particularly suitable for patients with chronic diseases (e.g., diabetes).

2. Comprehensive Treatment Model:

The unique “LIPUS + Psychological Counseling + VR” holistic treatment model combines physiological repair with psychological intervention, improving patient satisfaction by over 30%.

3. Clinical Data:

Supported by clinical validation from over 60 medical institutions worldwide, its efficacy and safety have been endorsed by authoritative institutions such as UCSF (University of California, San Francisco) and Peking University Hospital.

Conference Overview

1.Date: October 30 - November 1, 2025  

2.Venue: Shanghai International Conference Center (No. 2727, Binjiang Avenue, Pudong New District, Shanghai)

OCUA2025 is not only an academic feast but also an important opportunity for urology and andrology professionals across Asia to collaborate. WBL Medical Group cordially invites experts from around the world to visit Booth B04 and discuss technological innovations and the future development of the field. We look forward to seeing you in Shanghai and embarking on a new chapter in andrology diagnosis and treatment。